Tildrakizumab use for recalcitrant pityriasis rubra pilaris

IF 2.2 4区医学 Q2 DERMATOLOGY

Australasian Journal of Dermatology Pub Date : 2024-05-30 DOI:10.1111/ajd.14307

Zachary Holmes MBBChBAO, MSc, MRCP, Michelle S. Goh MBBS, FACD, Peter Foley MD, FACD, Benjamin S. Daniel MBBS, MMed, FACD

引用次数: 0

Abstract Image

查看原文本刊更多论文

Tildrakizumab 用于治疗顽固性红斑狼疮。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Australasian Journal of Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

5.00%

发文量

186

审稿时长

6-12 weeks

期刊介绍： Australasian Journal of Dermatology is the official journal of the Australasian College of Dermatologists and the New Zealand Dermatological Society, publishing peer-reviewed, original research articles, reviews and case reports dealing with all aspects of clinical practice and research in dermatology. Clinical presentations, medical and physical therapies and investigations, including dermatopathology and mycology, are covered. Short articles may be published under the headings ‘Signs, Syndromes and Diagnoses’, ‘Dermatopathology Presentation’, ‘Vignettes in Contact Dermatology’, ‘Surgery Corner’ or ‘Letters to the Editor’.